Ebola
Mologic Awarded £1M to Develop POC Test for SARS-CoV-2
The company is working with the Institut Pasteur de Dakar to validate and manufacture the test at a new manufacturing site in DiaTropix, Senegal.
Mologic, Institut Pasteur de Dakar to Develop Ebola Rapid Diagnostic Test
The partners are validating three rapid diagnostic test prototypes prior to initiating a trial in the Democratic Republic of the Congo during March 2020.
OraSure Technologies Rapid Ebola Test Granted Marketing Authorization by FDA
The test, which detects antibodies to Ebola virus from whole-blood samples and cadaveric oral fluid, was also granted breakthrough device designation.
The agency plans to evaluate newer RDTs in the future, and it is collaborating to bring molecular testing nearer to patients.
The company developed the test with Boston University researchers as part of an effort to push its surface-enhanced Raman scattering tech for POC applications.
Aug 29, 2018
Jul 30, 2018
Mar 16, 2017
Jun 5, 2015